SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-13-055216
Filing Date
2013-10-25
Accepted
2013-10-25 20:42:01
Documents
1
Period of Report
2013-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rrd393532.html 4/A  
1 FORM 4/A rrd393532.xml 4/A 3634
  Complete submission text file 0001181431-13-055216.txt   4905
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
TIDMARSH GEORGE F (Reporting) CIK: 0001287235 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-24274 | Film No.: 131171863